$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000143774920012660 Filed on June 08, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q1
Revenue	$307.1K	$522.5K	$551.6K
YoY Change	-57.83%	-5.28%	-34.44%
Cost Of Revenue	$148.5K	$124.3K	$604.1K
YoY Change	-78.15%	-79.43%	-48.79%
Gross Profit	$158.7K	$398.2K	-$52.43K
YoY Change	224.14%	-859.57%	-84.49%
Gross Profit Margin	51.67%	76.22%	-9.5%
Selling, General & Admin	$1.212M	$1.381M	$1.377M
YoY Change	14.48%	0.32%	-5.8%
% of Gross Profit	763.72%	346.89%
Research & Development	$318.6K	$336.9K	$374.1K
YoY Change	5.76%	-9.95%	-4.6%
% of Gross Profit	200.75%	84.6%
Depreciation & Amortization	$20.00K	$19.91K	$19.29K
YoY Change	-93.55%	3.21%	-8.22%
% of Gross Profit	12.6%	5.0%
Operating Expenses	$1.531M	$1.718M	$1.751M
YoY Change	12.55%	-1.88%	-5.55%
Operating Profit	-$200.9K	-$2.050M	$70.00
YoY Change	74.98%	-2928980.0%	-100.0%
Interest Expense	$567.5K	$1.551M
YoY Change	394.07%
% of Operating Profit
Other Income/Expense, Net	-$1.372M	-$1.320M	-$1.804M
YoY Change	4.64%	-26.81%	-30059733.33%
Pretax Income	-$1.570M	-$3.370M	-$1.800M
YoY Change	9.79%	87.22%	-17.81%
Income Tax
% Of Pretax Income
Net Earnings	-$1.573M	-$3.370M	-$1.804M
YoY Change	10.31%	86.87%	-17.72%
Net Earnings / Revenue	-512.05%	-645.05%	-326.95%
Basic Earnings Per Share
Diluted Earnings Per Share	-$601.5K	-$1.774M	-$1.029M
COMMON SHARES
Basic Shares Outstanding	21.60M		13.99M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.400M	$1.170M	$460.0K
YoY Change	102.9%	154.35%	-64.62%
Cash & Equivalents	$886.7K	$661.9K	$459.3K
Short-Term Investments	$520.0K	$510.0K
Other Short-Term Assets	$79.63K	$130.7K	$75.82K
YoY Change	-42.53%	72.33%	40.3%
Inventory	$388.9K	$388.9K	$980.9K
Prepaid Expenses
Receivables	$315.3K	$120.3K	$740.4K
Other Receivables	$70.00K	$130.0K	$80.00K
Total Short-Term Assets	$2.285M	$1.990M	$3.557M
YoY Change	-40.08%	-44.05%	-34.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$95.55K	$75.60K	$152.7K
YoY Change	-30.49%	-50.5%	-20.88%
Goodwill	$417.2K
YoY Change
Intangibles	$2.147M	$147.2K	$194.3K
YoY Change	1024.1%	-24.24%	10.76%
Long-Term Investments
YoY Change
Other Assets	$190.0K	$220.0K	$310.0K
YoY Change	-34.48%	-29.03%	-16.22%
Total Long-Term Assets	$3.467M	$1.029M	$7.707M
YoY Change	-52.78%	-86.64%	-11.2%
TOTAL ASSETS
Total Short-Term Assets	$2.285M	$1.990M	$3.557M
Total Long-Term Assets	$3.467M	$1.029M	$7.707M
Total Assets	$5.752M	$3.019M	$12.28M
YoY Change	-48.44%	-75.42%	-24.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$668.5K	$617.0K	$472.6K
YoY Change	-22.71%	30.54%	86.82%
Accrued Expenses	$380.5K	$515.1K	$578.0K
YoY Change	-46.73%	-10.88%	10.16%
Deferred Revenue	$602.8K	$413.3K	$333.2K
YoY Change	104.85%	24.04%
Short-Term Debt	$500.0K	$2.370M	$0.00
YoY Change	-7.41%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.623M	$4.077M	$1.655M
YoY Change	71.32%	146.28%	8.79%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$350.0K	$350.0K	$420.0K
YoY Change	-7.89%	-16.67%
Total Long-Term Liabilities	$346.1K	$353.6K	$419.2K
YoY Change	-9.65%	-15.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.623M	$4.077M	$1.655M
Total Long-Term Liabilities	$346.1K	$353.6K	$419.2K
Total Liabilities	$4.970M	$4.430M	$1.816M
YoY Change	61.26%	143.9%	19.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$94.78M	-$93.21M	-$76.94M
YoY Change	20.95%	21.14%	15.11%
Common Stock	$2.218K	$1.839K	$1.399K
YoY Change	55.21%	31.45%	47.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$782.5K	-$1.411M	$9.189M
YoY Change
Total Liabilities & Shareholders Equity	$5.752M	$3.019M	$12.28M
YoY Change	-48.44%	-75.42%	-24.73%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$1.573M	-$3.370M	-$1.804M
YoY Change	10.31%	86.87%	-17.72%
Depreciation, Depletion And Amortization	$20.00K	$19.91K	$19.29K
YoY Change	-93.55%	3.21%	-8.22%
Cash From Operating Activities	-$950.0K	-$1.023M	$160.5K
YoY Change	126.19%	-737.28%	-84.62%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$23.39K
YoY Change	-100.0%		-28.81%
Acquisitions
YoY Change
Other Investing Activities	-$1.900M	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$1.910M		-$25.13K
YoY Change			-23.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.070M	1.606M
YoY Change	372.31%
NET CHANGE
Cash From Operating Activities	-950.0K	-1.023M	160.5K
Cash From Investing Activities	-1.910M		-25.13K
Cash From Financing Activities	3.070M	1.606M
Net Change In Cash	210.0K	582.9K	135.4K
YoY Change	-8.7%	330.62%	-86.61%
FREE CASH FLOW
Cash From Operating Activities	-$950.0K	-$1.023M	$160.5K
Capital Expenditures	$0.00		$23.39K
Free Cash Flow	-$950.0K	-$1.023M	$137.1K
YoY Change	131.71%	-846.0%	-86.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q1	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	413687
CY2019Q1	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature
CY2020Q1	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights
CY2019Q1	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	281074
CY2020Q1	bkyi	Beneficial Conversion Feature BeneficialConversionFeature	641215
CY2019Q1	bkyi	Beneficial Conversion Feature BeneficialConversionFeature
CY2019Q3	bkyi	Class Of Warrant Or Right Recorded As Debt Discount ClassOfWarrantOrRightRecordedAsDebtDiscount	595662
CY2020Q1	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact	-900000
CY2020Q1	bkyi	Common Stock Issued For Loan Commitment Fees CommonStockIssuedForLoanCommitmentFees	132500
CY2019Q1	bkyi	Common Stock Issued For Loan Commitment Fees CommonStockIssuedForLoanCommitmentFees
CY2020Q1	bkyi	Deemed Dividend Related To Down Round Features DeemedDividendRelatedToDownRoundFeatures
CY2020Q1	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	-112500
CY2019Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	-122064
CY2020Q1	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	243170
CY2019Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	233005
CY2020Q1	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
CY2020Q1	bkyi	Factoring Fees FactoringFees	32000
CY2019Q1	bkyi	Factoring Fees FactoringFees	52797
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001019034
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21598544
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	dei	Trading Symbol TradingSymbol	bkyi
CY2020Q1	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	13659
CY2019Q1	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	13709
CY2020Q1	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-44587
CY2019Q1	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-32897
CY2020Q1	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-5028
CY2019Q1	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-26130
CY2019	bkyi	Investment In Held To Maturity Debt Securities Term InvestmentInHeldToMaturityDebtSecuritiesTerm	P1Y
CY2019Q4	bkyi	Investment In Heldtomaturity Debt Securities Interest Rate InvestmentInHeldtomaturityDebtSecuritiesInterestRate	0.05
CY2019Q4	bkyi	Limit Of Bond LimitOfBond	20000000
CY2020Q1	bkyi	Monthly Cash Requirement To Conduct Operations And Pay Dividend Obligations MonthlyCashRequirementToConductOperationsAndPayDividendObligations	525000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Banker Fees PaymentsOfStockIssuanceCostsBankerFees	193500
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Commitment Fees PaymentsOfStockIssuanceCostsCommitmentFees	50000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Legal Fees PaymentsOfStockIssuanceCostsLegalFees	71330
CY2020Q1	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
CY2019	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
CY2020Q1	bkyi	Percentage Of Support And Maintenance Revenue To License Cost PercentageOfSupportAndMaintenanceRevenueToLicenseCost	0.18
CY2020Q1	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	512719
CY2019Q1	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	509528
CY2020Q1	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	68774
CY2019Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	73802
CY2020Q1	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants
CY2019Q1	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	16505
CY2019Q3	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	266667
CY2020Q1	bkyi	Stock Issued During Period Value Conversion Of Warrant StockIssuedDuringPeriodValueConversionOfWarrant	1458000
CY2019Q3	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	400000
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	BIO KEY INTERNATIONAL INC
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2020Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	130670
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	110941
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	616985
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	844557
CY2020Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1854078
CY2019Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1859785
CY2020Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	134078
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	139785
CY2020Q1	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2019Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2020Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	120293
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	126000
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	120293
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	126000
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	515108
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	572885
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	91793124
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	87436402
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	641215
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	512719
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	509528
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	512719
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	526033
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	218061
CY2019Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	878398
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7164
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3314
CY2019Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6957516
CY2020Q1	us-gaap	Assets Assets	3019278
CY2019Q4	us-gaap	Assets Assets	2496698
CY2020Q1	us-gaap	Assets Current AssetsCurrent	1990004
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1366291
CY2020Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1029274
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1130407
CY2020Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	36679
CY2019Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	33510
CY2020Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	661937
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79013
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	323943
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	459311
CY2020Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	582924
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	135368
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.60
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.65
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18391122
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14411432
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18391122
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14411432
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	1839
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1441
CY2020Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	208499
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	231519
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	413345
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	359212
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	413345
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	359212
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	72000
CY2019Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	124263
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	604050
CY2020Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	1500000
CY2019Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1
CY2020Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2020Q1	us-gaap	Depreciation Depreciation	19912
CY2019Q1	us-gaap	Depreciation Depreciation	19292
CY2020Q1	us-gaap	Dividends Paidinkind DividendsPaidinkind	41688
CY2020Q1	us-gaap	Dividends Paidinkind DividendsPaidinkind	112686
CY2019Q1	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2020Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	66466
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	188737
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2019Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	19142
CY2020Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-499076
CY2019Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020Q1	us-gaap	Gross Profit GrossProfit	398222
CY2019Q1	us-gaap	Gross Profit GrossProfit	-52427
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4000000
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2020Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-227572
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	124534
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5707
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-833613
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-57777
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	29764
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	54133
CY2019Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	136631
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-31408
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-17921
CY2020Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	19729
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58175
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	36928
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	147222
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	154386
CY2020Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	40995
CY2019Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized
CY2020Q1	us-gaap	Interest Expense InterestExpense	1551141
CY2019Q1	us-gaap	Interest Expense InterestExpense
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet
CY2020Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	256353
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	287761
CY2020Q1	us-gaap	Inventory Net InventoryNet	397711
CY2019Q4	us-gaap	Inventory Net InventoryNet	429119
CY2020Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141358
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141358
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	70
CY2020Q1	us-gaap	Lease Cost LeaseCost	53723
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	566320
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	89226
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	160817
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	170853
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	145424
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	49881
CY2020Q1	us-gaap	Liabilities Liabilities	4430299
CY2019Q4	us-gaap	Liabilities Liabilities	4781871
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3019278
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2496698
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4076746
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4391405
CY2020Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	353553
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	390466
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1605729
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25128
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1022805
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	160496
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-3370282
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-1803508
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3482968
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1803508
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	353553
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	390466
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	52301
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	520470
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	566479
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	46009
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	34864
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y47D
CY2020Q1	us-gaap	Other Assets Current OtherAssetsCurrent	130670
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1320066
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1803578
CY2020Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2301956
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2255454
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	1718288
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	1751151
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2050216
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	70
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	53723
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	516439
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	162886
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170560
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	110941
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	13000
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2020Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1737
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23391
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	166572
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	108397
CY2020Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;">Reclassifications</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><br /> Certain balance sheet accounts have been reclassified to conform to the <div style="display: inline; font-style: italic; font: inherit;">2020</div> presentation.</div></div></div></div>
CY2020Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	283000
CY2019Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt
CY2020Q1	us-gaap	Share Price SharePrice	0.76
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	520470
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1500000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1032500
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16506
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-1411021
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-2285173
CY2020Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-122271
CY2019Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1458000
CY2019Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	75597
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95509
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	336889
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	374118
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93205984
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89723016
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	522485
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	551623
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1381399
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1377033
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10466222
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	9188748
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	15165522
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13979318

Files In Submission

Name	View Source	Status
0001437749-20-012660-index-headers.html	Edgar Link	pending
0001437749-20-012660-index.html	Edgar Link	pending
0001437749-20-012660.txt	Edgar Link	pending
0001437749-20-012660-xbrl.zip	Edgar Link	pending
bkyi-20200331.xml	Edgar Link	completed
bkyi-20200331.xsd	Edgar Link	pending
bkyi-20200331_cal.xml	Edgar Link	unprocessable
bkyi-20200331_def.xml	Edgar Link	unprocessable
bkyi-20200331_lab.xml	Edgar Link	unprocessable
bkyi-20200331_pre.xml	Edgar Link	unprocessable
bkyi20200331_10q.htm	Edgar Link	pending
ex_189273.htm	Edgar Link	pending
ex_189274.htm	Edgar Link	pending
ex_189275.htm	Edgar Link	pending
ex_189276.htm	Edgar Link	pending
ex_189287.htm	Edgar Link	pending
ex_189288.htm	Edgar Link	pending
ex_189289.htm	Edgar Link	pending
ex_189290.htm	Edgar Link	pending
ex_189291.htm	Edgar Link	pending
ex_189292.htm	Edgar Link	pending
ex_189445.htm	Edgar Link	pending
ex_189445img001.jpg	Edgar Link	pending
ex_189446.htm	Edgar Link	pending
ex_189447.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2020 Q2 Form 10-Q Financial Statement

#000143774920012660 Filed on June 08, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2020 Q2 Form 10-Q Financial Statement

#000143774920012660 Filed on June 08, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi